Try our Advanced Search for more refined results

Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al

  1. January 21, 2025

    FDA Says 3 States' Mifepristone Suit Can't Be In Texas

    The U.S. Food and Drug Administration has renewed its effort to dismiss three states' challenge of the agency's approval of abortion medication mifepristone, arguing that the states have no plausible connection to the Northern District of Texas.

  2. January 16, 2025

    Texas Judge Says 3 States Can Pursue Mifepristone Suit

    A Texas federal judge said Thursday that Idaho, Missouri and Kansas can continue to challenge federal approvals for the abortion medication mifepristone in Texas federal court after private plaintiffs dropped their claims.

  3. January 01, 2025

    High-Stakes Healthcare Court Battles To Watch In 2025

    With pivotal health law cases on the docket in 2025, attorneys will be watching how the incoming Trump administration proceeds in ongoing litigation over abortion care, the Affordable Care Act and the Medicare drug price negotiation program.

  4. December 10, 2024

    United Health Denials, Patent Antitrust Fight And Neb. Pot Law

    United Healthcare must take a third look at its coverage denial for a patient's mental health and substance abuse treatment, and a former state senator asked the Nebraska Court of Appeals to wade into his fight against medical marijuana legalization. Here, Law360 Healthcare Authority looks at the significant cases and decisions that shaped the industry over the last week.

  5. December 06, 2024

    Biden Admin Says Abortion Drug Fight Can't Stay In Texas

    The Biden administration and mifepristone-maker Danco Laboratories LLC doubled down Friday on their bids to end the litigation challenging federal approvals for the abortion medication, arguing the three intervening states can't continue to litigate in Texas federal court now that the private plaintiffs have dropped their claims.

  6. November 20, 2024

    3 States To Challenge Abortion Regs After Docs Drop Claims

    Anti-abortion medical groups that were dealt a loss by the U.S. Supreme Court earlier this year have now dropped out of their lawsuit challenging federal approvals for mifepristone, leaving Missouri, Idaho and Kansas to carry on litigation over the abortion medication.

  7. January 23, 2024

    3 States Ask To Join High Court Case Against Abortion Drug

    Republican attorneys general in Missouri, Idaho and Kansas moved to join the case in the U.S. Supreme Court challenging federal approvals for the abortion medication mifepristone, asking the justices to ensure the challenge isn't dismissed for lack of standing.

  8. January 12, 2024

    Judge OKs Bid By 3 States To Join Suit Against Abortion Drug

    A Texas federal judge granted permission Friday for Missouri, Kansas and Idaho to join a lawsuit challenging federal approvals for the abortion medication mifepristone, ruling that the states have unique interests that aren't represented by others in the case.

  9. December 18, 2023

    Feds Say 3 States Can't Intervene In Abortion Pill Suit

    The federal government asked a Texas court to reject a motion for intervention in a dispute over the abortion drug mifepristone, arguing that there was no point in adding Missouri, Idaho and Kansas to the suit when the original plaintiffs who sued lacked sufficient standing.

  10. November 17, 2023

    Judge Won't Delay Ruling If States Can Join Abortion Pill Suit

    A Texas federal judge told the government to make its argument about why Missouri, Kansas and Idaho shouldn't intervene in a lawsuit over various rulings about the abortion drug mifepristone, saying that there's no need to wait for the U.S. Supreme Court to decide if it will review the case.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!